In addition, myricetin was found to downregulate extracellular signal-regulated kinase (ERK)/p90RSK/AP-1, janus-family tyrosine kinase 1 (JAK1)/signal transducer and activator of transcription (STAT), and PI3K/AKT pathways in cancer cells (64). This evidence concerns the gene MAPK1 and cancer.